Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 616-06-8
2. 2-aminohexanoic Acid
3. H-dl-nle-oh
4. Norleucine, Dl-
5. (+/-)-norleucine
6. 2-aminohexanoic Acid, Dl-
7. Hexanoic Acid, Amino-
8. Norleucine, (+/-)-
9. Dl-.alpha.-aminocaproic Acid
10. Mfcd00064422
11. 5c81be5gkk
12. Nsc74430
13. Nsc203799
14. Nsc-203799
15. Hexanoic Acid, (s)-
16. 2-amino-hexanoic Acid
17. (+-)-norleucine
18. .alpha.-aminocaproic Acid
19. Dl-2-aminohexanoic Acid
20. Dl-alpha-aminocaproic Acid
21. Unii-5c81be5gkk
22. Mfcd00008099
23. Mfcd00064423
24. 2-aminohexanoicacid
25. Einecs 210-462-7
26. Nsc 203799
27. (.+-.)-norleucine
28. Norleucine, (l)
29. (.+/-.)-norleucine
30. Schembl8392
31. (+/-)-2-aminocaproic Acid
32. Norleucine Dl-form [mi]
33. Chebi:36405
34. Dtxsid40861874
35. Nsc10378
36. Bbl011583
37. Nsc-74430
38. Stk943761
39. Akos000201118
40. Akos016053503
41. Am82585
42. Cs-w013425
43. Hy-w012709
44. Sb75379
45. (2r)-2-aminohexanoic Acid;d-norleucine
46. As-17286
47. Sy036145
48. Sy038236
49. Sy062052
50. Db-048259
51. Ft-0624339
52. Ft-0625493
53. Ft-0627603
54. N0302
55. En300-18344
56. N-8796
57. (+/-)-2-aminocaproic Acid, 2-aminohexanoic Acid
58. 616n068
59. A821399
60. J-300346
61. Q27116817
62. F2191-0205
63. 0ff7d875-44f8-41fa-8c5a-94108672bd95
64. 5157-09-5
| Molecular Weight | 131.17 g/mol |
|---|---|
| Molecular Formula | C6H13NO2 |
| XLogP3 | -1.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 131.094628657 g/mol |
| Monoisotopic Mass | 131.094628657 g/mol |
| Topological Polar Surface Area | 63.3 Ų |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Complexity | 93.1 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Norleucine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Norleucine, including repackagers and relabelers. The FDA regulates Norleucine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Norleucine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Norleucine supplier is an individual or a company that provides Norleucine active pharmaceutical ingredient (API) or Norleucine finished formulations upon request. The Norleucine suppliers may include Norleucine API manufacturers, exporters, distributors and traders.
Norleucine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Norleucine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Norleucine GMP manufacturer or Norleucine GMP API supplier for your needs.
A Norleucine CoA (Certificate of Analysis) is a formal document that attests to Norleucine's compliance with Norleucine specifications and serves as a tool for batch-level quality control.
Norleucine CoA mostly includes findings from lab analyses of a specific batch. For each Norleucine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Norleucine may be tested according to a variety of international standards, such as European Pharmacopoeia (Norleucine EP), Norleucine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Norleucine USP).
LOOKING FOR A SUPPLIER?
